跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tomolol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tomolol
Approved
STANDARD
Tomolol
Joint Stock Company "Farmak"
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
da9afc9d7025876a
Company
Joint Stock Company "Farmak"
Type
Standard
Approval Details
Approval Id
da9afc9d7025876a
Drug Approval Philippines Name
Tomolol
Product Name
Tomolol
Registration Number
DRP-12880
Brand Name
Tomolol
Generic Name
Timolol (As Maleate)
Dosage Form
Ophthalmic Solution
Dosage Strength
5 mg per mL
Manufacturer
Joint Stock Company "Farmak"
Importer
Suhitas Pharmaceuticals, Inc.
Distributor
Suhitas Pharmaceuticals, Inc.
Issuance Date
24 October 2022
Expiry Date
24 October 2027
Pharmacologic Category
Antiglaucoma preparation and Miotic (Beta Blocking Agent)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
da9afc9d7025876a
Type
Standard
Back to Philippines FDA Approvals